Vico Therapeutics

OverviewSuggest Edit

Vico Therapeutics is a company that develops ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarily affecting girls.
TypePrivate
Founded2019
HQLeiden, NL
Websitevicotx.com

Latest Updates

Employees (est.) (Oct 2020)23(+22%)
Cybersecurity ratingDMore

Vico Therapeutics Office Locations

Vico Therapeutics has an office in Leiden
Leiden, NL (HQ)
Biopartner center Leiden, J.H. Oortweg 21
Show all (1)

Vico Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2019

Vico Therapeutics total Funding

$31 m

Vico Therapeutics latest funding size

$31 m

Time since last funding

3 months ago

Vico Therapeutics investors

Vico Therapeutics's latest funding round in July 2020 was reported to be $31 m. In total, Vico Therapeutics has raised $31 m
Show all financial metrics

Vico Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

D

66/100

SecurityScorecard logo

Vico Therapeutics Online and Social Media Presence

Embed Graph

Vico Therapeutics News and Updates

Dutch Vico Therapeutics strengthens leadership team with the appointment of Rupert Sandbrink as Chief Medical Officer and Anders Hinsby as Independent Director

LEIDEN, The Netherlands, Oct. 1, 2020 /PRNewswire/ -- Vico Therapeutics, a Leiden, the Netherlands, based biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, today announced the appointment of Rupert Sandbrink, M.D., Ph.D., as the...

Vico Therapeutics Raises $31M in Series A Financing

Vico Therapeutics, a Leiden, Netherlands-based biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, raised $31m (€27m) in Series A financing round. The round was led by Life Science Partners (LSP), co-led by Kurma Partners, and supported by Pontifa…

Vico Therapeutics Frequently Asked Questions

  • When was Vico Therapeutics founded?

    Vico Therapeutics was founded in 2019.

  • How many employees does Vico Therapeutics have?

    Vico Therapeutics has 23 employees.

  • Who are Vico Therapeutics competitors?

    Competitors of Vico Therapeutics include Sansheng Biological Technology, Arcutis Biotherapeutics and Amphivena Therapeutics.

  • Where is Vico Therapeutics headquarters?

    Vico Therapeutics headquarters is located at Biopartner center Leiden, J.H. Oortweg 21, Leiden.

  • Where are Vico Therapeutics offices?

    Vico Therapeutics has an office in Leiden.

  • How many offices does Vico Therapeutics have?

    Vico Therapeutics has 1 office.